MDWD vs USNA
Mediwound Ltd. and Usana Health Sciences, Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | MDWD | USNA |
|---|---|---|
| Revenue | $17.0M | $925.3M |
| Net income | $-23.9M | $10.8M |
| Gross margin | 19.2% | 78.3% |
| Net margin | −140.8% | 1.2% |
| Return on equity | — | 2.0% |
| Diluted EPS | −$2.10 | $0.58 |
| Dividend / share | — | — |
| Payout ratio | — | — |
| Free cash flow | $-21.6M | $8.5M |
| Equity | — | $533.1M |
| Net debt / equity | — | — |
| Current ratio | 2.33× | 2.24× |
| Revenue CAGR 5y | −4.9% | −4.0% |
| Profit CAGR 5y | — | −38.7% |
USNA bills 54.6× the revenue of MDWD, and MDWD closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | MDWD | USNA |
|---|---|---|
| FY2025 | $17.0M | $925.3M |
| FY2024 | $20.2M | $854.5M |
| FY2023 | $18.7M | $921.0M |
| FY2022 | $26.5M | $998.6M |
| FY2021 | $23.8M | $1.2B |
| FY2020 | $21.8M | $1.1B |
| FY2019 | $31.8M | $1.1B |
| FY2018 | $3.4M | $1.2B |
| FY2017 | $2.5M | $1.0B |
| FY2016 | $1.6M | $1.0B |
Net income by year
Bottom line
| Fiscal year | MDWD | USNA |
|---|---|---|
| FY2025 | $-23.9M | $10.8M |
| FY2024 | $-30.2M | $42.0M |
| FY2023 | $-6.7M | $63.8M |
| FY2022 | $-19.6M | $69.3M |
| FY2021 | $-13.6M | $116.5M |
| FY2020 | $-9.2M | $124.7M |
| FY2019 | $5.0M | $100.5M |
| FY2018 | $-1.1M | $126.2M |
| FY2017 | $-22.1M | $62.5M |
| FY2016 | $-18.9M | $100.0M |
Advertisement
AdSense · Rectangle 336×280
More in this industry